KP Tissue (TSE:KPT) Releases Quarterly Earnings Results

Posted by on May 16th, 2026

KP Tissue (TSE:KPT – Get Free Report) posted its earnings results on Thursday. The company reported C$0.22 earnings per share (EPS) for the quarter, reports.

Here are the key takeaways from KP Tissue’s conference call:

  • KP Tissue reported Q1 2026 adjusted EBITDA of CAD 86.9 million, up 14.6% year over year, with margin improving to 16.0% from 13.9% on the back of lower pulp and warehousing costs.
  • Revenue was essentially flat at CAD 544.6 million, as modest growth in Canada was offset by a decline in U.S. sales and unfavorable foreign exchange.
  • The company said its operations outperformed targets across all sites, and the new Memphis converting line ramped as planned in early Q2 to add capacity to the U.S. network.
  • Management reiterated plans for a new western U.S. TAD tissue plant, targeting an official announcement by the end of the first half of 2026 and startup in late 2028.
  • Executives flagged rising fuel, freight and other input costs as a key watch item, saying they will consider pricing actions if needed, while Q2 adjusted EBITDA is expected to be in line with Q1.

KP Tissue Price Performance

Shares of KPT stock opened at C$11.64 on Friday. KP Tissue has a 1-year low of C$8.66 and a 1-year high of C$11.95. The firm’s 50-day simple moving average is C$11.11 and its 200-day simple moving average is C$10.52. The firm has a market cap of C$116.57 million, a P/E ratio of 13.69, a PEG ratio of -0.88 and a beta of 0.47.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. Desjardins upped their price target on KP Tissue from C$12.00 to C$12.50 and gave the stock a “hold” rating in a report on Friday. National Bank Financial upped their target price on KP Tissue from C$10.00 to C$11.00 and gave the stock a “sector perform” rating in a research note on Monday, February 2nd. Finally, TD increased their target price on KP Tissue from C$11.00 to C$12.00 and gave the company a “hold” rating in a research report on Friday. Four investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, KP Tissue has a consensus rating of “Hold” and an average price target of C$11.10.

Check Out Our Latest Stock Analysis on KP Tissue

About KP Tissue

(Get Free Report)

KP Tissue Inc operates as a holding company. The firm produces, distributes, markets, and sells a range of disposable tissue products in North America. It offers bathroom and facial tissues, paper towels, paper towels, and napkins, as well as disposable wiping products and washroom dispensing systems.

Read More

Earnings History for KP Tissue (TSE:KPT)

Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.